NOVARTIS AG (NVSEF)
Clinical trial NCT07467993 updates: 1. completion date: 2027-04-22 → 2027-07-29 2. primary completion date: 2027-04-22 → 2027-07-29
Clinical trial NCT07467993 updates: 1. completion date: 2027-04-22 → 2027-07-29 2. primary completion date: 2027-04-22 → 2027-07-29
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical